Olema Pharmaceuticals, Inc. (US:OLMA) has institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission . Olema Pharmaceuticals Inc. ; Prev. Close. ; Low. ; 52wk Low. ; Market Cap. m ; Total Shares. m. Get the latest updates on Olema Pharmaceuticals, Inc. Common Stock (OLMA) pre market trades, share volumes, and more. Make informed investments with Nasdaq. Olema Pharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next. 04, (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Stock Information. NASDAQ GS: OLMA. $ 0 (%). Image Stock Chart.
Stock Price Forecast. The 5 analysts with month price forecasts for OLMA stock have an average target of 27, with a low estimate of 20 and a high estimate of. View the OLMA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Olema Pharmaceuticals. Olema Pharmaceuticals Inc OLMA:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date11/08/23 · 52 Week Low. OLMA Olema Pharmaceuticals · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. M · Turnover Ratio. % · P/E (Static). Olema Oncology (Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on targeted therapies for women's cancers, has announced the granting of stock. Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next. Olema Pharmaceuticals Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Stock Price Forecast. The 5 analysts with month price forecasts for OLMA stock have an average target of 27, with a low estimate of 20 and a high estimate of. Olema Pharmaceuticals Inc ; Mar PM · Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule (c)(4). (GlobeNewswire) % ; Feb The current price of OLMA is USD — it hasn't changed in the past 24 hours. Watch Olema Pharmaceuticals, Inc. stock price performance more closely on the. OLMA Stock Overview · Analysts in good agreement that stock price will rise by % · Makes less than USD$1m in revenue ($0) · Shareholders have been diluted.
Olema Pharmaceuticals, Inc. (mdv-yk242.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Olema Pharmaceuticals. Recent News · Olema Oncology price target lowered to $31 from $33 at JPMorgan · Buy Rating Reaffirmed for Olema Pharmaceuticals Amid Promising Breast Cancer. Olema Pharmaceuticals (NASDAQ:OLMA) Is In A Good Position To Deliver On Growth Plans. Just because a business does not make any money, does not mean that the. Olema Pharmaceuticals Inc. · AFTER HOURS PM EDT 08/23/24 · % · AFTER HOURS Vol , The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Compared to the closing price on Friday 08/23/ on BTT of $, this is a drop of %. There are M shares outstanding in Olema Pharmaceuticals Inc. What was Olema Pharmaceuticals's price range in the past 12 months? Olema Pharmaceuticals lowest stock price was $ and its highest was $ in the past Over the last year, Olema Pharmaceuticals, Inc.'s stock price has increased by %. Olema Pharmaceuticals, Inc. is currently approximately $ per share. Track Olema Pharmaceuticals Inc (OLMA) Stock Price, Quote, latest community messages, chart, news and other stock related information.
On average, Wall Street analysts predict that Olema Pharmaceuticals's share price could reach $ by Aug 8, The average Olema Pharmaceuticals stock. Discover real-time Olema Pharmaceuticals, Inc. Common Stock (OLMA) stock prices, quotes, historical data, news, and Insights for informed trading and. Olema Pharmaceuticals (NASDAQ:OLMA) Stock Quotes, Forecast and News Summary ; Volume / Avg. K / K ; Day Range, $ - $ ; 52 Wk Range, -. About Olema Pharmaceuticals (OLMA) ; Yesterday's range. $ - $ ; Debt / equity. x ; 52 week range. $ - $ ; 5 year debt / equity. x ; Beta . Olema Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in discovery, development and commercialization of therapies for women's.
The average one-year price target for Olema Pharmaceuticals, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price. Olema Pharmaceuticals Inc. ; Volume, K ; Market Value, $M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. OLMA's current price target is $ Learn why top analysts are making this stock forecast for Olema Pharmaceuticals at MarketBeat. Highlights · The debt has declined by 11% since the previous quarter and by % year-on-year · Olema Pharmaceuticals's equity has increased by 41% YoY but it has. Olema Pharmaceuticals Inc. (OLMA) Stock Performance ; Olema Pharmaceuticals (OLMA). , ; BSE Sensex. , ; S&P Small-Cap · , Hold. 0 ; Current $ ; Target $ ; Technicals Summary. Sell. Neutral. Buy. Olema Pharmaceuticals Inc is currently in a neutral trading position according.
Site To Borrow Money Instantly | Making Your Credit Score Higher Fast